SMEPPI: An indenone derivative that selectively inhibits M1 macrophage activation and enhances phagocytic activity
Authors:
Open Access
- 14 January 2025
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 183, 117856
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
This publication has 41 references indexed in Scilit:
- Indanone: a promising scaffold for new drug discovery against neurodegenerative disordersDrug Discovery Today, 2024
- Cationic Gold‐Catalyzed Intramolecular Cyclization of Substituted 1,5‐Diynes to Access Indenone DerivativesChemistry – An Asian Journal, 2022
- A novel indenone derivative selectively induces senescence in MDA-MB-231 (breast adenocarcinoma) cellsChemico-Biological Interactions, 2020
- Homeostasis, Inflammation, and Disease SusceptibilityCell, 2015
- Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia–reperfusion in SK-N-SH cellsBrain Research, 2011
- Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammationBiochemical Pharmacology, 2010
- Augmentation of PPARγ-TAZ interaction contributes to the anti-adipogenic activity of KR62980Biochemical Pharmacology, 2009
- PPAR γ partial agonist, KR-62776, inhibits adipocyte differentiation via activation of ERKCellular and Molecular Life Sciences, 2009
- Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell linesInvestigational New Drugs, 2008
- KR-62980: A novel peroxisome proliferator-activated receptor γ agonist with weak adipogenic effectsBiochemical Pharmacology, 2006